Recently, significant aberration in neurofilament light chain (NfL) levels have been associated with Alzheimer’s disease (AD) [12], amyotrophic lateral sclerosis [13], multiple sclerosis [14] and cerebral vascular disease [15]. The gene discussed is NEFL; the disease is Alzheimer disease.